These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23482636)

  • 21. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spermatogenic cells distal to the blood-testis barrier in rats lack C3 convertase regulators and may be at risk of complement-mediated injury.
    Mizuno M; Harris CL; Morgan BP
    J Reprod Immunol; 2006 Feb; 69(1):23-34. PubMed ID: 16380167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel chicken membrane-associated complement regulatory protein: molecular cloning and functional characterization.
    Inoue N; Fukui A; Nomura M; Matsumoto M; Nishizawa Y; Toyoshima K; Seya T
    J Immunol; 2001 Jan; 166(1):424-31. PubMed ID: 11123320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.
    Mold C; Walter EI; Medof ME
    J Immunol; 1990 Dec; 145(11):3836-41. PubMed ID: 1700997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
    Wright A; Morrison SL
    J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
    Oglesby TJ; White D; Tedja I; Liszewski K; Wright L; Van den Bogarde J; Atkinson JP
    Trans Assoc Am Physicians; 1991; 104():164-72. PubMed ID: 1726964
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
    Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway.
    Carlsson F; Sandin C; Lindahl G
    Mol Microbiol; 2005 Apr; 56(1):28-39. PubMed ID: 15773976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection.
    Fearon DT; Austen KF
    N Engl J Med; 1980 Jul; 303(5):259-63. PubMed ID: 6900901
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
    Saint-Remy JM
    Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering of human complement component C3 for catalytic inhibition of complement.
    Kölln J; Bredehorst R; Spillner E
    Immunol Lett; 2005 Apr; 98(1):49-56. PubMed ID: 15790508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi's sarcoma-associated herpesvirus.
    Pyaram K; Kieslich CA; Yadav VN; Morikis D; Sahu A
    J Immunol; 2010 Feb; 184(4):1956-67. PubMed ID: 20089702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
    Rooijakkers SH; Ruyken M; Roos A; Daha MR; Presanis JS; Sim RB; van Wamel WJ; van Kessel KP; van Strijp JA
    Nat Immunol; 2005 Sep; 6(9):920-7. PubMed ID: 16086019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement C3 isoforms in Austrelaps superbus.
    Rehana S; Kini RM
    Toxicon; 2008 Apr; 51(5):864-81. PubMed ID: 18262580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner.
    Papadakos KS; Ekström A; Slipek P; Skourti E; Reid S; Pietras K; Blom AM
    J Exp Clin Cancer Res; 2022 Dec; 41(1):363. PubMed ID: 36578014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pan-cancer analysis of Sushi domain-containing protein 4 (SUSD4) and validated in colorectal cancer.
    Zhong Y; Zheng C; Zhang W; Wu H; Zhang Q; Li D; Ju H; Feng H; Chen Y; Fan Y; Chen W; Wang M; Wang G
    Aging (Albany NY); 2024 Apr; 16(7):6417-6444. PubMed ID: 38579174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of host from its own complement by membrane-bound complement inhibitors: C3 convertase inhibitors vs membrane attack complex inhibitors.
    Kinoshita T
    Res Immunol; 1996 Feb; 147(2):100-3. PubMed ID: 8792468
    [No Abstract]   [Full Text] [Related]  

  • 40. The Complement Regulator Susd4 Influences Nervous-System Function and Neuronal Morphology in Mice.
    Zhu H; Meissner LE; Byrnes C; Tuymetova G; Tifft CJ; Proia RL
    iScience; 2020 Mar; 23(3):100957. PubMed ID: 32179479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.